These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9596882)
1. [Apoptosis and malignant gynecological tumors]. Yang Y; Shen J; Lang J Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):121-4. PubMed ID: 9596882 [No Abstract] [Full Text] [Related]
2. [Blood groups (ABO system) as pathogenetic and risk factors in gynecological tumors]. Galeazzi L; Gualandri V Minerva Ginecol; 1971 Feb; 23(3):144-7. PubMed ID: 5092552 [No Abstract] [Full Text] [Related]
3. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048 [TBL] [Abstract][Full Text] [Related]
4. p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines. Rantanen V; Grénman S; Kurvinen K; Hietanen S; Raitanen M; Syrjänen S Gynecol Oncol; 1998 Dec; 71(3):352-8. PubMed ID: 9887230 [TBL] [Abstract][Full Text] [Related]
5. Germline polymorphism of p53 codon 72 in gynecological cancer. Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468 [TBL] [Abstract][Full Text] [Related]
6. Clinical importance of molecular determinations in gynecologic patients with multiple tumors. Dinjens WN; van der Burg ME; Chadha S; Sleddens HF; Burger CW; Ewing PC Cancer; 2003 Apr; 97(7):1766-74. PubMed ID: 12655534 [TBL] [Abstract][Full Text] [Related]
7. Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors. Addeo R; Crisci S; D'Angelo V; Vincenzi B; Casale F; Pettinato G; Donofrio V; Boldrini R; Alaggio R; Collini P; Bertorelle R; Di Tullio MT; Caraglia M; Terenziani M; Lo Curto M; Indolfi P Oncol Rep; 2007 May; 17(5):1155-61. PubMed ID: 17390059 [TBL] [Abstract][Full Text] [Related]
8. [On the possibility of the onset of malignant neoplasms following roentgen-castration for uterine myofibromas and other benign gynecological diseases]. Blandino G; Micali A; Minutoli A; Scolarici L Radiol Med; 1965 Dec; 51(12):1302-19. PubMed ID: 5177088 [No Abstract] [Full Text] [Related]
9. [Oncogenes in gynecological malignancies]. Zhang X Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):643-6. PubMed ID: 8745485 [No Abstract] [Full Text] [Related]
10. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206 [TBL] [Abstract][Full Text] [Related]
11. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681 [TBL] [Abstract][Full Text] [Related]
12. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887 [TBL] [Abstract][Full Text] [Related]
13. [TP53 mutations and molecular epidemiology]. Otsuka K; Ishioka C Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437 [TBL] [Abstract][Full Text] [Related]
14. [Risk factors for tumors of the female genitalia]. Bennardo R; Autelitano M Ann Ig; 1991; 3(2):123-32. PubMed ID: 1725592 [No Abstract] [Full Text] [Related]
15. [Role of the p53 and bcl-2 genes in apoptosis and drug resistance of tumors]. Luk'ianova NIu; Kulik GI; Chehun VF Vopr Onkol; 2000; 46(2):121-8. PubMed ID: 10853407 [No Abstract] [Full Text] [Related]
16. Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma. van Slooten HJ; van De Vijver MJ; Borresen AL; Eyfjörd JE; Valgardsdóttir R; Scherneck S; Nesland JM; Devilee P; Cornelisse CJ; van Dierendonck JH J Pathol; 1999 Dec; 189(4):504-13. PubMed ID: 10629550 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. Caserini C; Pratesi G; Tortoreto M; Bedogné B; Carenini N; Supino R; Perego P; Righetti SC; Zunino F Clin Cancer Res; 1997 Jun; 3(6):955-61. PubMed ID: 9815771 [TBL] [Abstract][Full Text] [Related]
19. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters]. Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599 [TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma. Sato S; Kigawa J; Minagawa Y; Okada M; Shimada M; Takahashi M; Kamazawa S; Terakawa N Cancer; 1999 Oct; 86(7):1307-13. PubMed ID: 10506718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]